In contrast, increased FGFR2 activity is found in several other cancers, including activating mutations in endometrial [64,65], lung [66], and gastric cancer [64], and amplifications and overexpression of FGFR2 in gastric and breast cancer [64]. This evidence concerns the gene FGFR2 and breast cancer.